Difference in toxicity of beta-amyloid peptide with aging in relation to nerve growth factor content in rat brain

Journal of Neural Transmission
T FukutaT Nabeshima

Abstract

Amyloid beta-peptide (Abeta) is the major constituent of the senile plaques in the brains of patients with Alzheimer's disease. We have demonstrated previously that memory impairment, dysfunction of the cholinergic and dopaminergic neuronal system and morphological degeneration are produced after the continuous infusion of Abeta into the cerebral ventricle in 8-week-old rat. In the present study, we investigated the toxicity of Abeta in infant (10 days old), adult (8 weeks old) and aged (20 months old) rats in relation to nerve growth factor (NGF) content in various regions of the brain. After a 2-week-infusion, choline acetyltransferase (ChAT) activity was significantly decreased in the hippocampus of adult, but not infant or aged rats. NGF levels in the hippocampus were increased only in adult rats. These results suggest that Abeta is toxic only in the matured adult brain, and that the mechanism of toxicity is related to NGF synthesis.

References

May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B HengererH Thoenen
Apr 1, 1989·Stroke; a Journal of Cerebral Circulation·P Nyberg, S Waller
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L R WilliamsF H Gage
Aug 1, 1985·Journal of the Neurological Sciences·I ElovaaraT Erkinjuntti
Nov 1, 1982·Journal of the Neurological Sciences·G K Wilcock, M M Esiri
Nov 1, 1994·The Tohoku Journal of Experimental Medicine·T Nabeshima, A Nitta
Mar 28, 1994·Neuroscience Letters·A NittaT Nabeshima
Jul 21, 1998·European Journal of Pharmacology·K YamadaT Nabeshima
Aug 14, 1998·Dementia and Geriatric Cognitive Disorders·M Eriksdotter JönhagenL O Wahlund
Apr 13, 1999·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·R HellwegJ Cervós-Navarro
Nov 11, 1999·European Journal of Pharmacology·A ItohT Nabeshima

❮ Previous
Next ❯

Citations

Dec 17, 2003·Neurobiology of Aging·Luigi BrunettiMichele Vacca
Sep 3, 2011·Behavioural Brain Research·Caroline ChambonWojciech Danysz
Feb 26, 2009·Aging Cell·Julien BrubanFrédéric Mascarelli
Dec 25, 2004·Neuropharmacology·Neelima B ChauhanDouglas L Feinstein
Dec 14, 2004·Stroke; a Journal of Cerebral Circulation·Shawn N WhiteheadDavid F Cechetto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.